B of A Securities Reinstates Neutral on Cardlytics, Announces $11 Price Target
B of A Securities Reinstates Neutral on Cardlytics, Announces $11 Price Target
B of A證券重新給予cardlytics中立評級，宣佈11美元的目標價。
B of A Securities analyst Omar Dessouky reinstates Cardlytics (NASDAQ:CDLX) with a Neutral and announces $11 price target.
美國銀行證券分析師Omar Dessouky以中立的態度恢復了Cardlytics (NASDAQ:CDLX)的評級，並宣佈了11美元的目標價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。